Effects of endothelin-1 on capsaicin-induced nociception in mice

European Journal of Pharmacology

Volumn 351, Issue 1, 1998, Pages 15-22

  Piovezan, Anna P ^a   D'Orléans Juste, Pedro ^b   Tonussi, Carlos R ^a   Rae, Giles A ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Endothelin; Endothelin receptor antagonist; Hyperalgesia (mouse); Inflammation; Pain

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; BOSENTAN; CAPSAICIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SARAFOTOXIN S6C; SEROTONIN 1 RECEPTOR; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL;

ANALGESIA; ANIMALS; CAPSAICIN; DANSYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENDOTHELINS; HINDLIMB; HYPERALGESIA; MALE; MICE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SEROTONIN; SULFONAMIDES;

EID: 0345267053     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00281-7     Document Type: Article

References (43)

1. 2A receptors potentiates pain produced by inflammatory mediators. Neuropharmacology 35, 99-110.
2. Arai, H., Hori, S., Aramori, I., Ohkubo, H., Nakanishi, S., 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730-732.
3. Bertelli, A., Clerico, A., Chicca, A., Giovannini, L., Gorio, A., Romano, M.A., 1992. Role of endothelin-1 in carrageenin-induced inflammation. Int. J. Tissue React. 14, 225-230.
4. Carstens, E., 1995. Neural mechanisms of hyperalgesia: peripheral or central sensitization?. News Physiol. Sci. 10, 260-265.
5. Caterina, M.J., Schummacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D., Julius, D., 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824.
6. Clozel, M., Breu, V., Gray, G.A., Kalina, B., Löffler, B.-M., Burri, K., Cassal, J.-M., Hirth, G., Müller, M., Neidhart, W., Ramuz, H., 1994. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270, 228-235.
7. Cunha, F.Q., Lorenzetti, B.B., Poole, S., Ferreira, S.H., 1991. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104, 765-767.
8. Dahlof, B., Gustafsson, D., Hedner, D., Jern, S., Hansson, L., 1990. Regional hemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactions. J. Hypertens. 8, 811-817.
9. Duarte, I.D., dos Santos, I.R., Lorenzetti, B.B., Ferreira, S.H., 1992. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 217, 225-227.
10. Dymshitz, J., Vasko, M.R., 1994. Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci. Lett. 167, 128-132.
11. Ferreira, S.H., 1993. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs 46, 1-9, Suppl. 1.
12. Ferreira, S.H., Romitelli, M., De Nucci, G., 1989. Endothelin-1 participation in overt and inflammatory pain. J. Cardiovasc. Pharmacol. 13, S220-S222, Suppl. 5.
13. Ferreira, S.H., Lorenzetti, B.B., Poole, S., 1993. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110, 1227-1231.
14. Ferreira, S.H., Lorenzetti, B.B., Devissageut, M., Lesieur, D., Tsouderos, Y., 1995. S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance. Br. J. Pharmacol. 114, 303-308.
15. B receptors. Br. J. Pharmacol. 115, 227-236.
16. Fukuoka, H., Kawatani, M., Hisamitsu, T., Takeshige, C., 1994. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 657, 133-140.
17. Helset, E., Sildnes, T., Selkelid, R., Konopski, Z.S., 1993. Endothelin-1 stimulates human monocytes in vitro to release TNF-α, interleukin-β and interleukin-6. Med. Inflamm. 2, 417-422.
18. Holzer, P., 1991. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev. 43, 143-201.
19. Hunskaar, S., Hole, K., 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30, 103-114.
20. Hyslop, S., De Nucci, G., 1992. Vasoactive mediators released by endothelins. Pharmacol. Res. 26, 223-242.
21. Ishida, K., Takeshige, K., Minakami, S., 1990. Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenyl-alanine. Biochem. Biophys. Res. Commun. 173, 496-500.
22. Klemm, P., Warner, T.D., Hohlfeld, T., Corder, R., Vane, J.R., 1995. Endothelin-1 mediates ex vivo coronary vasoconstriction caused by exogenous cytokine. Proc. Natl. Acad. Sci. U.S.A. 92, 2691-2695.
23. Masaki, T., Vane, J.R., Vanhoutte, P.M., 1994. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 46, 137-142.
24. McCarron, R.M., Wang, L., Stanimirovic, D.B., Spatz, M., 1993. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci. Lett. 156, 31-34.
25. Piovezan, A.P., D'Orleans-Juste, P., Tonussi, C.R., Rae, G.A., 1997. Endothelins potentiate formalin-induced nociception and paw edema in mice. Can. J. Physiol. Pharmacol. 75, 596-600.
26. Rae, G.A., Henriques, M.G.M.O., 1998. Endothelins in inflammation. In: Said, S. (Ed.), Pro-Inflammatory and Anti-inflammatory Peptides, Marcel Dekker, New York, pp. 163-202.
27. Raffa, R.B., Jacoby, H.I., 1991. Endothelin-1, -2 and -3 directly and big-endothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sci. 48, PL85-PL90.
28. B receptors. J. Pharmacol. Exp. Ther. 276, 647-651.
29. Sakurada, T., Katsumata, K., Tan-No, K., Sakurada, S., Kisara, K., 1992. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 31, 1279-1285.
30. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., Masaki, T., 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348, 732-735.
31. Shibata, M., Ohkubo, T., Takahashi, H., Inoki, R., 1989. Modified formalin test: characteristic biphasic pain response. Pain 38, 347-352.
32. Stankova, J., D'Orléans-Juste, P., Rola-Pleszczynki, M., 1996. ET-1 induces interleukin-6 gene expression in human umbilical vein endothelial cells: synergistic effect of interleukin-1. Am. J. Physiol. 271, C1073-C1078.
33. Stein, C., Millan, M.J., Herz, A., 1988. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol. Biochem. Behav. 31, 445-451.
34. Stein, P.D., Hunt, J.T., Floyd, D.M., Moreland, S., Dickenson, K.E.J., Mitchell, C., Liu, E.C.-K., Webb, M.L., Murugesan, N., Dickey, J., McMullen, D., Zhang, R., Lee, V.G., Serafino, R., Delaney, C., Schaeffer, T.R., Zozlowski, M., 1994. The discovery of sulfonamide endothelin antagonist and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulphonamide. J. Med. Chem. 37, 329-331.
35. Sugiura, M., Inagami, T., Kon, V., 1989. Endotoxin stimulated endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161, 1220-1227.
36. Szallasi, A., 1995. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol. Scand. 155, 1-68, Suppl. 629.
37. Tonussi, C.R., Ferreira, S.H., 1994. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitization. Eur. J. Pharmacol. 251, 173-179.
38. Vemulapalli, S., Chiu, P.J., Griscti, K., Brown, A., Kurowski, S., Sybertz, E.J., 1994. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur. J. Pharmacol. 257, 95-102.
39. Webb, D.J., 1997. Endothelin: from molecule to man. Br. J. Clin. Pharmacol. 44, 9-20.
40. Webb, M.L., Meek, T.D., 1997. Inhibitors of endothelin. Med. Res. Rev. 17, 17-67.
41. Yamamura, H., Nabe, T., Kohno, S., Ohata, K., 1994. Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur. J. Pharmacol. 265, 9-15.
42. Yoshizawa, T., Kimura, S., Kanazawa, I., Uchiyama, Y., Yanagisawa, M., Masaki, T., 1989. Endothelin localizes in the dorsal horn and act on the spinal cord neurones: possible involvement of dihydropyridine-sensitive calcium channels and substance P release. Neurosci. Lett. 102, 179-184.
43. Zimmermann, M., 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.